Early Redemption and Cancellation of 4th Series Convertible Bonds Worth 1.24 Billion Won
SD BIOTECHNOLOGIES decided to acquire and cancel its 4th series unsecured private convertible bonds with a face value of 1.175 billion won at a total cost of 1.242 billion won (including interest) due to bondholders' exercise of put option.
The convertible bonds were issued on December 20, 2023, with a conversion price of 500 won per share and a maturity date of December 19, 2028.
The acquisition was funded with internal cash, and the acquisition date was June 22, 2026.
After the acquisition, the total face value of the bonds is zero, completely eliminating existing debt and potential equity dilution.
KOSDAQ Filing Information
Filing: Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) Before Maturity After Issuance (4th Series)